We conducted a prospective single-blind randomized study to assess whether a single @,@ IU dose of human recombinant erythropoietin ( HRE ) , given just @ days before cardiac surgery , could be effective in reducing perioperative allogeneic red blood cell transfusion ( aRBCt ) .